Breathe Well Live Well
|
Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled …
MarketWatch (press release) "We are strongly committed to advancing a pipeline of iCALM therapies to treat chronic respiratory diseases, including COPD, asthma and cystic fibrosis." "iCALM's ability to limit allergen-induced eosinophilic airway inflammation in this trial is … |
View full post on asthma – Google News
|
NexBio Presents Data at ACAAI 2010 Demonstrating Mechanism of Action for …
PR Newswire (press release) NexBio presented nonclinical data at ACAAI 2009 from studies in three animal models of asthma, demonstrating that DAS181 inhibits airway hyperreactivity … |
View full post on asthma – Google News
|
Promedior Announces Publication Of New Research Demonstrating Pentraxin-2/SAP …
Medical News Today (press release) "Further investigation of the therapeutic effect of PTX-2/SAP in clinical asthma progression and exacerbation is a promising area for future research. … |
View full post on asthma – Google News
|
Promedior Announces Publication of New Research Demonstrating Pentraxin-2/SAP …
Bradenton Herald “Further investigation of the therapeutic effect of PTX-2/SAP in clinical asthma progression and exacerbation is a promising area for future research. … |
View full post on asthma – Google News